Your browser doesn't support javascript.
loading
Potential role of adjuvant drugs on efficacy of first line oral antitubercular therapy: Drug repurposing.
Mishra, Ritu; Krishan, Shri; Siddiqui, Ali Nasir; Kapur, Prem; Khayyam, Khalid Umer; Sharma, Manju.
Afiliação
  • Mishra R; Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
  • Krishan S; Department of Drug Safety and Pharmacovigilance, Syneos Health Gurgaon, 122002, India.
  • Siddiqui AN; Department of Pharmaceutical Medicine, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
  • Kapur P; Department of Medicine, Hamdard Institute of Medical Sciences and Research & Hakeem Abdul Hameed Centenary Hospital, Jamia Hamdard, New Delhi, 110062, India.
  • Khayyam KU; Department of Epidemiology & Public Health, National Institute of Tuberculosis & Respiratory Diseases, New Delhi, 110030, India.
  • Sharma M; Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. Electronic address: msharma@jamiahamdard.ac.in.
Tuberculosis (Edinb) ; 120: 101902, 2020 01.
Article em En | MEDLINE | ID: mdl-32090863

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Adjuvantes Imunológicos / Reposicionamento de Medicamentos / Mycobacterium tuberculosis / Antituberculosos Limite: Humans Idioma: En Revista: Tuberculosis (Edinb) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Índia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Adjuvantes Imunológicos / Reposicionamento de Medicamentos / Mycobacterium tuberculosis / Antituberculosos Limite: Humans Idioma: En Revista: Tuberculosis (Edinb) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Índia País de publicação: Reino Unido